Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cord Blood Stem Cells

Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies

Abstract

HCT is currently the treatment of choice for children with severe primary immunodeficiencies (PIDs). Frequently, these patients lack an HLA-identical sibling donor, and umbilical cord blood (UCB) transplantation may be an option; however, experience in this field remains scant. Fifteen children with PID (SCID 11, X-linked lymphoproliferative syndrome 2, Omenn's syndrome 1, Wiskott–Aldrich syndrome 1) received a UCB transplant. The donor was unrelated in 14 cases and related in 1. Median age at transplant was 11.6 months (range, 2.9–68.0) and median weight 7 kg (range, 4–21). Thirteen patients were conditioned with busulphan and cyclophosphamide and 2 with fludarabine and melphalan. Nine patients received antithymocyte globulin. Median NC × 107/kg infused was 7.9 (range, 2.9–25.0) and median CD34 × 105/kg 2.9 (range, 1.0–7.9). All patients engrafted. Median days to >0.5 × 109/l neutrophils was 31. Eight patients developed acute graft-versus-host disease (GvHD) grades II–IV and one chronic GvHD. Viral and fungal infections were frequent. Four patients died: three from GvHD grade IV complicated by infection and one from progressive interstitial lung disease. Five-year survival was 0.73±0.12. All surviving patients presented complete immunologic reconstitution. No patient is intravenous immunoglobulin (IVIg) replacement therapy-dependent. UCB transplantation is a valid option for children with PID who lack an HLA-identical sibling donor.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Taylor N, Weinberg K . Congenital defects of T lymphocyte function. Intern J Ped Hematol Oncol 1996; 3: 415–424.

    Google Scholar 

  2. Cavazzana-Calvo M, Lagresle C, Hacein-Bey AS, Fisher A . Gene therapy for severe combined immunodeficiency. Annu Rev Med 2005; 56: 585–602.

    Article  CAS  PubMed  Google Scholar 

  3. Gaspar HB, Parsley K, Howe S, King D, Kimberley CG, Sinclair J et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gamma retroviral vector. Lancet 2004; 364: 2181–2187.

    Article  CAS  PubMed  Google Scholar 

  4. Fisher A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A et al. European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 1990; 336: 850–854.

    Article  Google Scholar 

  5. Antoine C, Muller S, Cant A, Cavazzano-Calvo M, Veys P, Vosen J et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–1999. Lancet 2003; 361: 553–560.

    Article  PubMed  Google Scholar 

  6. Buckley RH, Schiff SE, Schiff RI, Market ML, Williams LW, Roberts JL et al. Hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508–516.

    Article  CAS  PubMed  Google Scholar 

  7. Fisher A, Landais P, Friedrich W, Geritsen B, Fasth A, Porta F et al. Bone marrow transplantation in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for immunodeficiency. Blood 1994; 83: 1149–1154.

    Google Scholar 

  8. Ozsahin H, Le Deist F, Benkerrou M, Cavazzama-Calvo M, Gomez L, Griscelli C et al. Bone marrow transplantation in 26 patients with Wiskott–Aldrich syndrome from a single center. J Pediatr 1996; 129: 238–244.

    Article  CAS  PubMed  Google Scholar 

  9. Gatti RA, Meewissen HJ, Allen HD, Hong R, Good R . Immunological reconstitution of sex-linked lymphogenic immunological deficiency. Lancet 1968; 2: 1366–1369.

    Article  CAS  PubMed  Google Scholar 

  10. Parkman R, Rappeport J, Geha R, Belli J, Cassady R, Levey R et al. Complete correction of the Wiskott–Aldrich syndrome by allogeneic bone marrow transplantation. N Engl J Med 1978; 298: 921–927.

    Article  CAS  PubMed  Google Scholar 

  11. Reisner Y, Kapoor N, Kirpatrick D, Pollack MS, Cunningham-Rudies D, Dupont B et al. Transplantation for severe combined immunodeficiency with HL-A, B, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341–348.

    CAS  PubMed  Google Scholar 

  12. Myers LA, Patel DD, Puck JM, Buckley RH . Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99: 872–878.

    Article  CAS  PubMed  Google Scholar 

  13. Haddad E, Landais P, Friedrich N, Gerritsen B, Cavazzana-Calvo M, Morgan G et al. Long-term immune reconstitution and outcome after HLA non-identical T-cell depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998; 91: 3646–3653.

    CAS  PubMed  Google Scholar 

  14. Filipovich AH, Shapiro RS, Ramsay NKC, Kim T, Blazar B, Kersey J et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80: 270–276.

    CAS  PubMed  Google Scholar 

  15. Dalal J, Reid B, Doyle J, Freedman M, Calderword S, Saunders F et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant 2005; 25: 613–626.

    Article  Google Scholar 

  16. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott–Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598–1603.

    Article  CAS  PubMed  Google Scholar 

  17. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies S, Ramsay NKC et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donor; analysis of engraftment and acute graft-versus host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  18. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord blood transplantation from related and unrelated donors. N Eng J Med 1997; 337: 373–382.

    Article  CAS  Google Scholar 

  19. Barker JN, Davies SM, de For T, Ramsay NKC, Weisdof DJ, Wagner JE . Survival after transplantation of unrelated umbilical cord blood is comparable to that of leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  PubMed  Google Scholar 

  20. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.

    Article  CAS  PubMed  Google Scholar 

  21. Ziegner UHM, Ochs HD, Schanen C, Feig SA, Seyama K, Futatoni T et al. Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 2001; 138: 570–573.

    Article  CAS  PubMed  Google Scholar 

  22. Benito A, Diaz MA, Alonso F, Fontan G, Madero L . Successful unrelated umbilical cord blood transplantation in a child with Omenn's syndrome. Pediatr Hematol Oncol 1999; 16: 361–366.

    Article  CAS  PubMed  Google Scholar 

  23. Fagioli F, Biaxin E, Berger M, Nesi F, Saroglia EH, Minero R et al. Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency. Bone Marrow Transplant 2003; 31: 133–136.

    Article  CAS  PubMed  Google Scholar 

  24. Knutsen AP, Steffen M, Wassmer K, Wall DA . Umbilical cord blood transplantation in Wiskott–Aldrich syndrome. J Pediatr 2003; 142: 519–523.

    Article  PubMed  Google Scholar 

  25. Vowels MR, Reg LPT, Berdukas V, Ford D, Thierry D, Purtilo D et al. Correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 1993; 329: 1623–1625.

    Article  CAS  PubMed  Google Scholar 

  26. Mino E, Kobayashi R, Yoshida M, Suzuki Y, Yamada M, Kobayashi K . Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia. Bone Marrow Transplant 2004; 33: 969–971.

    Article  CAS  PubMed  Google Scholar 

  27. Schwinger N, Urban CH, Lackner CH, Benesch M, Kerbl R, Dornbusch HJ et al. Unrelated 5/6-locus matched umbilical cord blood transplantation in a 23-month-old child with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 1998; 22: 393–396.

    Article  CAS  PubMed  Google Scholar 

  28. Ortega JJ, Yaniv I, Rocha V, Garnier F, Ebell W, Souillet G, et al., on behalf of Eurocord Transplant Group. Cord blood transplantation for inborn errors. Blood 1998; 10 (Suppl 1): 92 (abstract no. 291).

    Google Scholar 

  29. Ortega JJ, Rocha V, Wall D, Filipovich A, Porcher R, Pasquini R et al. Unrelated cord blood transplant in children with severe primary immunodeficiencies. A Eurocord analysis. Blood 2001; 11 (Suppl 1): 98 (abstract no. 667).

    Google Scholar 

  30. Knutsen AP, Wall DA . Umbilical cord blood transplantation in severe T cell immunodeficiency disorders: two-year experience. J Clin Immunol 2000; 20: 466–476.

    Article  CAS  PubMed  Google Scholar 

  31. Tsuji Y, Imai K, Kajiwara A, Aoki Y, Isoda T, Tomizawa D et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years' experience of a single team. Bone Marrow Transplant 2006; 37: 469–477.

    Article  CAS  PubMed  Google Scholar 

  32. Bhattacharya A, Slatter MA, Chapman CE, Barge D, Jackson A, Flood TJ et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005; 36: 295–299.

    Article  CAS  PubMed  Google Scholar 

  33. Comans-Bitter WM, de Groot R, van den BR . Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 1997; 130: 388–393.

    Article  CAS  PubMed  Google Scholar 

  34. Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emmanuel D et al. Analysis of engraftment, graft-versus-host disease and immune recovery following unrelated cord blood transplantation. Blood 2000; 96: 2703–2711.

    CAS  PubMed  Google Scholar 

  35. Giraud P, Thuret I, Revison D, Chambost H, Brunet C, Novakovitch G et al. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant 2000; 25: 53–57.

    Article  CAS  PubMed  Google Scholar 

  36. Niehues T, Rocha V, Filipovich AH, Chan KV, Porcher R, Michel G et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children—a Eurocord analysis. Br J Hematol 2001; 114: 42–48.

    Article  CAS  Google Scholar 

  37. Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–379.

    Article  CAS  PubMed  Google Scholar 

  38. Lankester AC, Visser LFA, Hartwig NG, Bredius RGM, Gaspar HB, van der Burg M et al. Allogeneic lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplant 2005; 36: 99–106.

    Article  CAS  PubMed  Google Scholar 

  39. Loechelt BJ, Shapiro RS, Jyonouchi H, Filipovich AH . Mismatched bone marrow transplantation for Omenn syndrome, a variant of severe combined immunodeficiency. Bone Marrow Transplant 1995; 16: 381–385.

    CAS  PubMed  Google Scholar 

  40. Rossi G, Zecca M, Giorgiani G, Bonetti F, De Stefano P, Locatelli F . Non-myeloablative stem cell transplantation for severe combined immunodeficiency-Omenn syndrome. Br J Haematol 2004; 125: 405–417.

    Article  Google Scholar 

  41. Rao K, Amnolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879–885.

    Article  CAS  PubMed  Google Scholar 

  42. Veys P, Rao K, Amrolia P . Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning. Bone Marrow Transplant 2005; 35: S45–S47.

    Article  PubMed  Google Scholar 

  43. Toren A, Nagler A, Amariglio N, Neumann Y, Golan H, Bilori B et al. Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immunodeficiency. Bone Marrow Transplant 1999; 23: 405–408.

    Article  CAS  PubMed  Google Scholar 

  44. Barker JN, Scaradavou A, Stevens CE, Rubinstein P . Analysis of 608 umbilical cord blood transplants: HLA is a critical determinant of transplant-related mortality in the post-engraftment period even in the absence of acute graft-vs-host disease. Blood 2005; 11 (Suppl 1): 102 (abstract no. 92).

    Google Scholar 

Download references

Acknowledgements

We thank Ms Christine O'Hara for her valuable assistance with the English version of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C Díaz de Heredia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Díaz de Heredia, C., Ortega, J., Díaz, M. et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant 41, 627–633 (2008). https://doi.org/10.1038/sj.bmt.1705946

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705946

Keywords

This article is cited by

Search

Quick links